Search | IOVS | ARVO Journals

Showing 1 – 20 of 23

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina July 2024

Differential Expression of Sex-Steroid Receptors in the Choroid Aligns With Central Serous Chorioretinopathy Sex Prevalence Across Different Ages

PDF

Sekar Galuh; Onno C. Meijer; Joost Brinks; Reinier O. Schlingemann; Camiel J. F. Boon; Robert M. Verdijk; Elon H. C. van Dijk
TAGS: central serous chorioretinopathy, choroid, gonadal steroid hormones, prevalence, electroconvulsive therapy, epidural cortical stimulation, stromal cells, premenopause
Invest. Ophthalmol. Vis. Sci.. 2024; 65(8):5. https://doi.org/10.1167/iovs.65.8.5

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

Shared genetic risk locus for central serous chorioretinopathy and varicose veins

Joel Rämö; Bryan Gorman; Lu-Chen Weng; Elon H. C. van Dijk; Panisa Singhanetr; Xin Wang; Michael B Gorin; Wen-Chih Wu; Suzanne Yzer; Neal Peachey; Joni Tururen; Camiel Boon; Patrick Ellinor; Mark Daly; Sudha K Iyengar; Elizabeth J Rossin

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4288.

ARVO Annual Meeting Abstract June 2024

Choroidal hyperpermeability patterns correlate with disease severity in central serous chorioretinopathy: CERTAIN study report 2.

Laurenz J. B. Pauleikhoff; Roselie M. H. Diederen; Jennifer M. Chang-Wolf; Annette C. Moll; Reinier O. Schlingemann; Elon H. C. van Dijk; Camiel J. F. Boon

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1727.

ARVO Annual Meeting Abstract June 2024

Immunolocalization of sex-steroid receptors in the human eye tissue across ages: an implication for pregnancy-associated central serous chorioretinopathy

Sekar Galuh; Onno Meijer; Joost Brinks; Reinier O. Schlingemann; Camiel Boon; Rob Verdijk; Elon H. C. van Dijk

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1281.

ARVO Annual Meeting Abstract June 2022

Safety and efficacy of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy

Helena Margaret Anthonia Feenstra; Roselie M.H. Diederen; Martine J.C.M. Lamme; Sascha Fauser; Susan M. Downes; Reinier O. Schlingemann; Carel C B Hoyng; Elon H.C. van Dijk; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):37.

ARVO Annual Meeting Abstract June 2022

Sex Hormones in Males and Females with Active Central Serous Chorioretinopathy

Joost Brinks; Elon H.C. van Dijk; Roula Tsonaka; Onno C. Meijer; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1180 – A0034.

ARVO Annual Meeting Abstract June 2022

Results of focal photocoagulation in polypoidal choroidal vasculopathy patients from a Dutch referral center

Marc J. Sirks; Helena Margaret Anthonia Feenstra; Florentine R. de Vries; Greet Dijkman; Camiel J F Boon; Elon H.C. van Dijk

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3768 – F0189.

ARVO Annual Meeting Abstract June 2022

Spontaneous resolution of subretinal fluid in chronic central serous chorioretinopathy: the Fuji sign

Camiel J F Boon; Helena Margaret Anthonia Feenstra; Jonathan Hensman; Theodora Gkika; Carel C B Hoyng; Roselie M.H. Diederen; Reinier O. Schlingemann; Susan M. Downes; Elon H.C. van Dijk

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3763 – F0184.

ARVO Annual Meeting Abstract July 2019

Corticosteroids and central serous chorioretinopathy: the role of the mineralocorticoid and glucocorticoid receptor in human choroidal endothelial cells

Joost Brinks; Elon H.C. van Dijk; Onno C. Meijer; Camiel Boon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4325.

Biochemistry and Molecular Biology November 2018

The Effect of Corticosteroids on Human Choroidal Endothelial Cells: A Model to Study Central Serous Chorioretinopathy

PDF

Joost Brinks; Elon H. C. van Dijk; Mahmoud Habeeb; Aikaterini Nikolaou; Roula Tsonaka; Hendrika A. B. Peters; Hetty C. M. Sips; Arjanneke F. van de Merbel; Eiko K. de Jong; Robbert G. E. Notenboom; Szymon M. Kielbasa; Silvère M. van der Maarel; Paul H. A. Quax; Onno C. Meijer; Camiel J. F. Boon
TAGS: adrenal corticosteroids, central serous chorioretinopathy, chronic exertional compartment syndrome, endothelial cells, glucocorticoids, hydrocortisone, mineralocorticoids, antagonists, agonists, patient isolation
Invest. Ophthalmol. Vis. Sci.. 2018; 59(13):5682-5692. https://doi.org/10.1167/iovs.18-25054

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

The effect of corticosteroids on human choroidal endothelial cells: a model to study central serous chorioretinopathy

Elon H. Van Dijk; Mahmoud Habeeb; Aikaterini Nikolaou; Joost Brinks; Roula Tsonaka; Hendrika Peters; Hetty Sips; Arjanneke van de Merbel; Eiko de Jong; Robbert Notenboom; Szymon Kielbasa; Silvère van der Maarel; Paul Quax; Onno Meijer; Camiel Boon

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1577.

ARVO Annual Meeting Abstract July 2018

Salivary alpha amylase activity is increased in active central serous chorioretinopathy

Lebriz Altay; Paula Scholz; Vasilena Sitnilska; Elon H. Van Dijk; Alberto M. Pereira; Femke M. van Haalen; Isha Akhtar; Camiel Boon; Sascha Fauser

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3128.

ARVO Annual Meeting Abstract July 2018

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy

Thomas Jurian van Rijssen; Elon H. Van Dijk; Greet Dijkman; Camiel Boon

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3134.

ARVO Annual Meeting Abstract July 2018

Pathophysiology of chemotherapy induced retinopathy

Elon H. Van Dijk

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4408.

ARVO Annual Meeting Abstract July 2018

Genome-wide association study underlines the role of the complement system in chronic central serous chorioretinopathy

Rosa Schellevis; Elon H. Van Dijk; Myrte Breukink; Lebriz Altay; Bjorn Bakker; Bobby Koeleman; Lambertus Kiemeney; Dorine Swinkels; Jan Keunen; Sascha Fauser; Carel C B Hoyng; Anneke I Den Hollander; Camiel Boon; Eiko de Jong

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4983.

ARVO Annual Meeting Abstract June 2017

Choroidal layer thickness in central serous retinopathy

Jay Chhablani; Daren Hanumunthadu; Elon HC van Dijk; Sunila Dumpala; Bindu Rajesh; Ayesha Jabeen; Asiya Jabeen; Momin Ansari; Pooja Mehta; Shilpi Shah; Chintan Sarvaiya; Catherine Meyerele; Lihteh Wu; Alay Banker; Giridhar Anantharaman; Camiel JF Boon

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1295.

ARVO Annual Meeting Abstract June 2017

Long-term phenotype changes in patients with chronic central serous chorioretinopathy.

Johann Roider; Konstantine Purtskhvanidze; Vladimir Sheptulin; Danial Mohabati; Elon HC van Dijk; Camiel J F Boon; Carel C B Hoyng

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1503.

ARVO Annual Meeting Abstract September 2016

Association analysis of functional variants in blood pressure regulation, blood clot formation and stress hormone binding genes with chronic central serous chorioretinopathy (cCSC)

Roos Schellevis; Myrte Breukink; Elon H.C. Van Dijk; Sascha Fauser; Camiel J F Boon; Eiko de Jong; Anneke I Den Hollander

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):646.

ARVO Annual Meeting Abstract September 2016

Central serous chorioretinopathy in primary hyperaldosteronism

Elon H.C. Van Dijk; Michiel Nijhoff; Eiko de Jong; Onno Meijer; Aiko De Vries; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5343.

ARVO Annual Meeting Abstract September 2016

Clinical characteristics and response to photodynamic therapy in severe phenotypes of chronic central serous chorioretinopathy

Danial Mohabati; Elon H.C. Van Dijk; Mays Talib; Eiko de Jong; Sascha Fauser; Carel C B Hoyng; Suzanne Yzer; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5355.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Differential Expression of Sex-Steroid Receptors in the Choroid Aligns With Central Serous Chorioretinopathy Sex Prevalence Across Different Ages

Shared genetic risk locus for central serous chorioretinopathy and varicose veins

Choroidal hyperpermeability patterns correlate with disease severity in central serous chorioretinopathy: CERTAIN study report 2.

Immunolocalization of sex-steroid receptors in the human eye tissue across ages: an implication for pregnancy-associated central serous chorioretinopathy

Safety and efficacy of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy

Sex Hormones in Males and Females with Active Central Serous Chorioretinopathy

Results of focal photocoagulation in polypoidal choroidal vasculopathy patients from a Dutch referral center

Spontaneous resolution of subretinal fluid in chronic central serous chorioretinopathy: the Fuji sign

Corticosteroids and central serous chorioretinopathy: the role of the mineralocorticoid and glucocorticoid receptor in human choroidal endothelial cells

The Effect of Corticosteroids on Human Choroidal Endothelial Cells: A Model to Study Central Serous Chorioretinopathy

The effect of corticosteroids on human choroidal endothelial cells: a model to study central serous chorioretinopathy

Salivary alpha amylase activity is increased in active central serous chorioretinopathy

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy

Pathophysiology of chemotherapy induced retinopathy

Genome-wide association study underlines the role of the complement system in chronic central serous chorioretinopathy

Choroidal layer thickness in central serous retinopathy

Long-term phenotype changes in patients with chronic central serous chorioretinopathy.

Association analysis of functional variants in blood pressure regulation, blood clot formation and stress hormone binding genes with chronic central serous chorioretinopathy (cCSC)

Central serous chorioretinopathy in primary hyperaldosteronism

Clinical characteristics and response to photodynamic therapy in severe phenotypes of chronic central serous chorioretinopathy

To View More...

You must be signed into an individual account to use this feature.